NA
Nitin Agrawal
About Nitin Agrawal
Data last updated:
Nitin Agrawal is a Cfo at Alkem Laboratories Limited (since 2024), Director at Adroit Biomed Limited (since 2025) and Director at Alkem Medtech Ortho Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Pharma, FMCG and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹15,355 Cr; the largest is Alkem Laboratories Limited at ₹15,296 Cr (FY 2026). Earlier, Nitin Agrawal was an Additional Director at Enzene Biosciences Limited (2018) and Cfo at Sahajanand Medical Technologies Limited (2021–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alkem Laboratories Limited L00305MH1973PLC174201 | Cfo | 01 Feb 2024 | 1973 | ₹15,296 Cr (FY 2026) | Active |
 Adroit Biomed Limited U22100MH2009PLC197761 | Director | 26 May 2025 | 2009 | ₹53.89 Cr (FY 2024) | Active |
 Alkem Medtech Ortho Private Limited U33309GJ2021PTC122834 | Director | 24 Apr 2025 | 2021 | ₹5.87 Cr (FY 2024) | Active |
| Alkem Wellness Limited U21002MH2024PLC432206 | Individual Subscriber | 16 Sep 2024 | 2024 | ₹6.3 Lakh (FY 2025) | Active |
| Alkem Medtech Private Limited U32509MH2024PTC422195 | Cfo | 18 Dec 2024 | 2024 | Active | |
| Alixer Nexgen Therapeutics Limited U21001MH2024PLC428703 | Individual Subscriber | 12 Jul 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Enzene Biosciences Limited U24232PN2006PLC165610 | Additional Director | 24 May 2018 | 2006 | ₹385 Cr (FY 2025) | Active |
 Sahajanand Medical Technologies Limited U33119GJ2001PLC040121 | Cfo | 03 May 2021 | 2001 | ₹1,036 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nitin Agrawal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitin Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitin Agrawal
Nitin Agrawal currently holds 6 directorships: Alkem Laboratories Limited (Cfo, since 01 Feb 2024, revenue ₹15,296 Cr (FY 2026)); Adroit Biomed Limited (Director, since 26 May 2025, revenue ₹53.89 Cr (FY 2024)); Alkem Medtech Ortho Private Limited (Director, since 24 Apr 2025, revenue ₹5.87 Cr (FY 2024)); Alkem Wellness Limited (Individual Subscriber, since 16 Sep 2024, revenue ₹6.3 Lakh (FY 2025)); Alkem Medtech Private Limited (Cfo, since 18 Dec 2024); and 1 more.
Nitin Agrawal was first appointed on 24 May 2018 as Additional Director at Enzene Biosciences Limited. The most recent appointment on record is 26 May 2025 at Adroit Biomed Limited.
The 4 current companies of Nitin Agrawal that report revenue have a combined latest revenue of ₹15,355 Cr: Alkem Laboratories Limited ₹15,296 Cr (FY 2026); Adroit Biomed Limited ₹53.89 Cr (FY 2024); Alkem Medtech Ortho Private Limited ₹5.87 Cr (FY 2024); Alkem Wellness Limited ₹6.3 Lakh (FY 2025).
Nitin Agrawal held 2 earlier board appointments: Enzene Biosciences Limited (Additional Director, 24 May 2018 to 17 Sep 2018); Sahajanand Medical Technologies Limited (Cfo, 03 May 2021 to 31 Jan 2024).
The current boards of Nitin Agrawal's companies include Basudeo Narayan Singh (Alkem Laboratories Limited), Diwakar Gupta (Alkem Laboratories Limited), Laxmana Ranjal Shenoy (Alkem Laboratories Limited), Madhurima Singh (Alkem Laboratories Limited), Manish Narang (Alkem Laboratories Limited), Mritunjay Kumar Singh (Alkem Laboratories Limited), among others.